Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose response of OPC-41061 (Tolvaptan) in CHF with edema
NCT00234104Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Aug 2004
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tolvaptan in heart failure (HF) and edema (4 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Body Weight at 7 days. Started Aug 2004; status: completed.
02
Drugs
tolvaptan
03
Conditions
heart failure (HF)edema
Beyond the preview
Go deeper on NCT00234104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234104.